Delivery Order SPE2DE21D7010-SPE2D625F4CGP
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, was awarded a $11,287.94 fixed-price delivery order (Contract 4569593362) by the Defense Logistics Agency (DLA) Medical Supply Chain on September 22, 2025. The delivery order, which includes economic price adjustment provisions, is designated for the MODULUS product line and has an ultimate completion date of September 23, 2025. The contract was awarded without set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and technologies, was awarded a delivery order valued at $8,533.00 by the Defense Logistics Agency (DLA) Medical Supply Chain on August 14, 2025. This fixed-price delivery order with economic price adjustment mechanism does not utilize any set-aside designation, indicating the contract was awarded through open market competition. The contract is scheduled for completion by August 15, 2025, and...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products, was awarded a $16,854 delivery order contract by the Defense Logistics Agency (DLA) Medical Supply Chain on April 30, 2025. This fixed-price contract with economic price adjustment provisions is classified as a delivery order with no set-aside designation, reflecting Nuvasive's competitive success in open market procurements. The contract is scheduled for completion by May 1, 2025, and will be...
- Nuvasive, Inc. was awarded a $11,287.94 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for the MODULUS spinal medical device on September 11, 2025, with completion scheduled for September 12, 2025. The contract, which carries no set-aside designation, reflects Nuvasive's competitive position in open market procurements for specialized spinal medical technologies. The place of performance is located in San Diego, California, where Nuvasive maintains its...
- Nuvasive, Inc. was awarded a $21,057.10 fixed-price delivery order with economic price adjustment on April 24, 2025, by the Defense Logistics Agency (DLA) Medical Supply Chain for the MODULUS spinal medical product line. The contract specifies a place of performance in San Diego, California, with an ultimate completion date of April 25, 2025. This delivery order carries no set-aside designation, indicating the award resulted from open market competition. Nuvasive, a subsidiary of Transplant...
- Nuvasive, Inc. has been awarded a $37,861.56 delivery order by the Defense Logistics Agency's Medical Supply Chain division, a defense-focused federal agency supporting Department of Defense and Veterans Affairs healthcare operations. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by September 18, 2025, and involves the delivery of specialized spinal medical technologies and surgical equipment to support military and veteran healthcare...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, received a $3,317.80 fixed-price delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on September 8, 2025, with an ultimate completion date of September 26, 2025. This contract award carries no set-aside designation and includes economic price adjustment provisions. The award supports the federal government's medical supply chain operations, which fall under the...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and services, received a delivery order award valued at $1,850.60 from the Defense Logistics Agency (DLA) Medical Supply Chain on July 17, 2025. The contract, designated as a fixed-price agreement with economic price adjustment mechanisms, carries an ultimate completion date of August 6, 2025. This award was issued without set-aside designation, indicating open market competition. The delivery...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $5,189.76 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025. The contract, designated as "SMALL INTERLOCK II," represents a fixed-price delivery order with economic price adjustment mechanisms and carries an ultimate completion date of September 22, 2025. The award was made without any set-aside designation,...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products, received a delivery order award valued at $8,533 from the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by September 22, 2025, and carries no set-aside designation, indicating competitive open-market procurement. The delivery order supports federal healthcare agencies,...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D625F4CGPDelivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and services, has been awarded a delivery order valued at $22,408.89 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 22, 2025. The contract, which carries no set-aside designation, is for the delivery of MODULUS spinal medical products and is structured as a fixed-price agreement with economic price adjustment provisions. Performance is scheduled to conclude by October 15, 2025, with work to be performed at the company's San Diego, California location. This award is issued under Nuvasive's established relationship with federal healthcare agencies, primarily supporting Department of Defense and Department of Veterans Affairs medical facilities. This delivery order represents a continuation of Nuvasive's ongoing support to the federal healthcare system through the DLA Medical Supply Chain procurement channel. The award is part of the company's broader portfolio of federal contract vehicles, including an $8 million Blanket Purchase Agreement with the Defense Health Agency that remains effective through March 2027. Nuvasive operates as a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division and has demonstrated consistent success in competitive federal procurements, delivering specialized spinal implants, fusion devices, surgical instruments, and biologics to support complex orthopedic and neurosurgical procedures across the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 9/22/25 |